Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 66 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function.
Ghazaly EA, Miraki-Moud F, Smith P, Gnanaranjan C, Koniali L, Oke A, Saied MH, Petty R, Matthews J, Stronge R, Joel SP, Young BD, Gribben J, Taussig DC
J Biol Chem, 295(16):5496-5508, 11 Mar 2020
Cited by: 4 articles | PMID: 32161116 | PMCID: PMC7170527
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models.
Maharaj L, Marson CM, Middleton BJ, Rioja AS, Perry J, Oakervee H, Cavenagh J, Joel SP, Popat R
Br J Haematol, 163(1):135-139, 09 Jul 2013
Cited by: 1 article | PMID: 23834265
Add to export list
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Al-Izki S, Pryce G, Hankey DJ, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C, Edith Chan AW, Amor S, Perkins V, Gerritsen WH, Ummenthum K, Peferoen-Baert R, van der Valk P, Montoya A, Joel SP, Garthwaite J, Giovannoni G, [...] Baker D
Brain, 137(pt 1):92-108, 27 Nov 2013
Cited by: 26 articles | PMID: 24287115
Add to export list
Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines.
Kassam S, Goenaga-Infante H, Maharaj L, Hiley CT, Juliger S, Joel SP
Cancer Chemother Pharmacol, 68(3):815-821, 26 Apr 2011
Cited by: 24 articles | PMID: 21519842
Add to export list
Methylseleninic acid antagonizes the cytotoxic effect of bortezomib in mantle cell lymphoma cell lines through modulation of Bcl-2 family proteins.
Kassam S, Juliger S, Jia L, Joel SP
Br J Haematol, 156(2):286-289, 13 Sep 2011
Cited by: 1 article | PMID: 21910718
Add to export list
Capabilities of HPLC with APEX-Q nebulisation ICP-MS and ESI MS/MS to compare selenium uptake and speciation of non-malignant with different B cell lymphoma lines.
Goenaga-Infante H, Kassam S, Stokes E, Hopley C, Joel SP
Anal Bioanal Chem, 399(5):1789-1797, 08 Dec 2010
Cited by: 3 articles | PMID: 21140135
Add to export list
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, Sharp S, Chaplin T, Xue L, McIntyre A, Shan L, Powles T, Oliver RT, Young BD, Shipley J, Berney DM, Joel SP, Lu YJ
Am J Pathol, 176(6):2607-2615, 15 Apr 2010
Cited by: 76 articles | PMID: 20395447 | PMCID: PMC2877824
Add to export list Free full text in Europe PMC
Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Noel EE, Perry J, Chaplin T, Mao X, Cazier JB, Joel SP, Oliver RT, Young BD, Lu YJ
Genes Chromosomes Cancer, 47(7):604-613, 01 Jul 2008
Cited by: 12 articles | PMID: 18384131
Add to export list
Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.
Jüliger S, Goenaga-Infante H, Lister TA, Fitzgibbon J, Joel SP
Cancer Res, 67(22):10984-10992, 01 Nov 2007
Cited by: 27 articles | PMID: 18006844
Add to export list
A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.
Seymour MT, Trigonis I, Finan PJ, Halstead F, Dunham R, Wilson G, Farrugia D, Chester JD, King J, Brown CB, Slevin ML, Joel SP
Eur J Surg Oncol, 34(4):403-409, 02 Jul 2007
Cited by: 1 article | PMID: 17604939
Add to export list
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Shamash J, Powles T, Ansell W, Berney D, Stebbing J, Mutsvangwa K, Wilson P, Asterling S, Liu S, Wyatt P, Joel SP, Oliver RT
Br J Cancer, 97(3):308-314, 03 Jul 2007
Cited by: 13 articles | PMID: 17609665 | PMCID: PMC2360316
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
Strauss SJ, Higginbottom K, Jüliger S, Maharaj L, Allen P, Schenkein D, Lister TA, Joel SP
Cancer Res, 67(6):2783-2790, 01 Mar 2007
Cited by: 68 articles | PMID: 17363600
Add to export list
Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
Marson CM, Mahadevan T, Dines J, Sengmany S, Morrell JM, Alao JP, Joel SP, Vigushin DM, Charles Coombes R
Bioorg Med Chem Lett, 17(1):136-141, 30 Sep 2006
Cited by: 6 articles | PMID: 17046252
Add to export list
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.
Strauss SJ, Maharaj L, Hoare S, Johnson PW, Radford JA, Vinnecombe S, Millard L, Rohatiner A, Boral A, Trehu E, Schenkein D, Balkwill F, Joel SP, Lister TA
J Clin Oncol, 24(13):2105-2112, 10 Apr 2006
Cited by: 100 articles | PMID: 16606971
Add to export list
Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides.
Marson CM, Savy P, Rioja AS, Mahadevan T, Mikol C, Veerupillai A, Nsubuga E, Chahwan A, Joel SP
J Med Chem, 49(2):800-805, 01 Jan 2006
Cited by: 5 articles | PMID: 16420064
Add to export list
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
Ord JJ, Streeter E, Jones A, Le Monnier K, Cranston D, Crew J, Joel SP, Rogers MA, Banks RE, Roberts IS, Harris AL
Br J Cancer, 92(12):2140-2147, 01 Jun 2005
Cited by: 19 articles | PMID: 15928663 | PMCID: PMC2361814
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Stability of morphine sulphate and diamorphine hydrochloride in intrasite gel.
Zeppetella G, Joel SP, Ribeiro MD
Palliat Med, 19(2):131-136, 01 Mar 2005
Cited by: 7 articles | PMID: 15810752
Add to export list
Clinical response to morphine in cancer patients and genetic variation in candidate genes.
Ross JR, Rutter D, Welsh K, Joel SP, Goller K, Wells AU, Du Bois R, Riley J
Pharmacogenomics J, 5(5):324-336, 01 Jan 2005
Cited by: 83 articles | PMID: 16103897
Add to export list
Morphine analgesia in cancer pain: role of the glucuronides.
Penson RT, Joel SP, Gloyne A, Clark S, Slevin ML
J Opioid Manag, 1(2):83-90, 01 May 2005
Cited by: 11 articles | PMID: 17319252
Add to export list
Lack of pharmacokinetic interaction between 5-fluorouracil and oxaliplatin.
Joel SP, Papamichael D, Richards F, Davis T, Aslanis V, Chatelut E, Locke K, Slevin ML, Seymour MT
Clin Pharmacol Ther, 76(1):45-54, 01 Jul 2004
Cited by: 13 articles | PMID: 15229463
Add to export list
The bioavailability of morphine applied topically to cutaneous ulcers.
Ribeiro MD, Joel SP, Zeppetella G
J Pain Symptom Manage, 27(5):434-439, 01 May 2004
Cited by: 26 articles | PMID: 15120772
Add to export list
s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line.
Liu WM, Strauss SJ, Chaplin T, Shahin S, Propper DJ, Young BD, Joel SP, Malpas JS
Hematol J, 5(3):247-254, 01 Jan 2004
Cited by: 15 articles | PMID: 15167912
Add to export list
Histone acetylation-mediated regulation of genes in leukaemic cells.
Chambers AE, Banerjee S, Chaplin T, Dunne J, Debernardi S, Joel SP, Young BD
Eur J Cancer, 39(8):1165-1175, 01 May 2003
Cited by: 68 articles | PMID: 12736119
Add to export list
The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration.
Liu WM, Joel SP
Cancer Chemother Pharmacol, 51(4):291-296, 05 Mar 2003
Cited by: 7 articles | PMID: 12721756
Add to export list
Structure-activity relationships of some opiate glycosides.
Stachulski AV, Scheinmann F, Ferguson JR, Law JL, Lumbard KW, Hopkins P, Patel N, Clarke S, Gloyne A, Joel SP
Bioorg Med Chem Lett, 13(6):1207-1214, 01 Mar 2003
Cited by: 7 articles | PMID: 12643945
Add to export list

1-25 of 66 results

1 2 3

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding